BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15453008)

  • 1. Factors contributing to failed trials of new agents: can technology prevent some problems?
    Greist JH; Mundt JC; Kobak K
    J Clin Psychiatry; 2002; 63 Suppl 2():8-13. PubMed ID: 15453008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
    Khan A; Schwartz K; Kolts RL; Ridgway D; Lineberry C
    Biol Psychiatry; 2007 Jul; 62(1):65-71. PubMed ID: 17141744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scales.
    Laenen A; Alonso A; Molenberghs G; Vangeneugden T; Mallinckrodt CH
    J Psychiatr Res; 2009 Apr; 43(7):730-8. PubMed ID: 18986657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From trial and error to trial simulation. Part 1: the importance of model-based drug development for antidepressant drugs.
    Santen G; van Zwet E; Danhof M; Della Pasqua O
    Clin Pharmacol Ther; 2009 Sep; 86(3):248-54. PubMed ID: 19657333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.
    Spielmans GI; McFall JP
    J Nerv Ment Dis; 2006 Nov; 194(11):845-52. PubMed ID: 17102709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comments on "Clinical trials of antidepressants: time to shift to a new model" by Dr Katz.
    Rickels K; Robinson DS
    J Clin Psychopharmacol; 2009 Apr; 29(2):197-8; author reply 198-9. PubMed ID: 19512995
    [No Abstract]   [Full Text] [Related]  

  • 7. Why the Hamilton Depression Rating Scale endures.
    Licht RW; Bech P
    Am J Psychiatry; 2005 Dec; 162(12):2394-5; author reply 2397-8. PubMed ID: 16330614
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment recommendations versus treatment realities: recognizing the rift and understanding the consequences.
    Frank E; Judge R
    J Clin Psychiatry; 2001; 62 Suppl 22():10-5. PubMed ID: 11599642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 10. Methodology to measure onset of action.
    Thase ME
    J Clin Psychiatry; 2001; 62 Suppl 15():18-21. PubMed ID: 11444762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer interviews for depression management.
    Greist JH
    J Clin Psychiatry; 1998; 59 Suppl 16():20-4; discussion 40-2. PubMed ID: 9796862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From trial and error to trial simulation. Part 2: an appraisal of current beliefs in the design and analysis of clinical trials for antidepressant drugs.
    Santen G; Horrigan J; Danhof M; Della Pasqua O
    Clin Pharmacol Ther; 2009 Sep; 86(3):255-62. PubMed ID: 19675543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An ideal trial to test differential onset of antidepressant effect.
    Leon AC; Blier P; Culpepper L; Gorman JM; Hirschfeld RM; Nierenberg AA; Roose SP; Rosenbaum JF; Stahl SM; Trivedi MH
    J Clin Psychiatry; 2001; 62 Suppl 4():34-6; discussion 37-40. PubMed ID: 11229787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?
    Zimmerman M; Mattia JI; Posternak MA
    Am J Psychiatry; 2002 Mar; 159(3):469-73. PubMed ID: 11870014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosing strategies for antidepressant clinical trials: a commentary.
    Robinson DS; Khan A
    J Clin Psychopharmacol; 2004 Feb; 24(1):1-3. PubMed ID: 14709939
    [No Abstract]   [Full Text] [Related]  

  • 16. Measuring onset of antidepressant action in clinical trials: an overview of definitions and methodology.
    Leon AC
    J Clin Psychiatry; 2001; 62 Suppl 4():12-6; discussion 37-40. PubMed ID: 11229782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction: defining remission in patients treated with antidepressants.
    Thase ME
    J Clin Psychiatry; 1999; 60 Suppl 22():3-6. PubMed ID: 10634348
    [No Abstract]   [Full Text] [Related]  

  • 18. Generalizability of antidepressant efficacy trials.
    Zimmerman M; Posternak MA; Chelminski I
    Essent Psychopharmacol; 2004; 6(1):45-58. PubMed ID: 15612653
    [No Abstract]   [Full Text] [Related]  

  • 19. An interactive voice response system to enhance antidepressant medication compliance.
    Stuart GW; Laraia MT; Ornstein SM; Nietert PJ
    Top Health Inf Manage; 2003; 24(1):15-20. PubMed ID: 12674391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational antidepressant selection in the elderly.
    Christensen DD
    Geriatrics; 1995 Oct; 50 Suppl 1():S41-50. PubMed ID: 7493749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.